Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Ottawa, Alberta agreed to extend $15-a-day child-care fees to 2027

December 12, 2025

Rare footage shows dolphins helping orcas hunt off B.C. coast

December 12, 2025

COMMENTARY: Possible relocation of Wildwood Golf Course is concerning residents

December 12, 2025

Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)

December 12, 2025

Driver, caregiver not to blame after child fatally struck by bus: Hamilton police

December 12, 2025
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 28, 2025
Press Release

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 28, 2025

By News RoomDecember 9, 20252 Mins Read
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 28, 2025
Share
Facebook Twitter LinkedIn Pinterest Email
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 28, 2025

NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — At the end of the settlement date of November 28, 2025, short interest in 3,453 Nasdaq Global MarketSM securities totaled 14,879,370,342 shares compared with 14,632,128,542 shares in 3,414 Global Market issues reported for the prior settlement date of November 14, 2025. The November short interest represents 2.22 days compared with 2.16 days for the prior reporting period.

Short interest in 1,698 securities on The Nasdaq Capital MarketSM totaled 3,311,934,829 shares at the end of the settlement date of November 28, 2025, compared with 3,326,683,612 shares in 1,697 securities for the previous reporting period. This represents a 1.00 day average daily volume; the previous reporting period’s figure was 1.00.

In summary, short interest in all 5,151 Nasdaq® securities totaled 18,191,305,171 shares at the November 28, 2025 settlement date, compared with 5,111 issues and 17,958,812,154 shares at the end of the previous reporting period. This is 1.82 days average daily volume, compared with an average of 1.75 days for the prior reporting period.

The open short interest positions reported for each Nasdaq security reflect the total number of shares sold short by all broker/dealers regardless of their exchange affiliations. A short sale is generally understood to mean the sale of a security that the seller does not own or any sale that is consummated by the delivery of a security borrowed by or for the account of the seller.

For more information on Nasdaq Short interest positions, including publication dates, visit
http://www.nasdaq.com/quotes/short-interest.aspx
or http://www.nasdaqtrader.com/asp/short_interest.asp.

About Nasdaq:
Nasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com.     

Media Contact: 
Sam Raffalli
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6814a1d3-8670-44ae-9909-dfb83b569c5a

NDAQO

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)

Alameda Health System reminds community: Apply for Medi-Cal before December 31, 2025

GeeFi Announces Major Community Giveaway to Celebrate Presale Success

Billor for Brokers Strengthens Specialized Freight Capacity with Live Bee Hauling Operations

GeeFi (GEE) Launches High-Reward Referral Program to Accelerate Community Growth

NurExone Plans Small-Scale of ExoPTEN Clinical Manufacturing in Preparation for FUTURE First in Human USE Pathways

Park Dental Partners Rings the Closing Bell on the Nasdaq in New York

Alpine Bank celebrates the enduring legacy of Founder J. Robert “Bob” Young

Over-the-Counter (OTC) Commodity Trading Platforms Market Report 2025

Editors Picks

Rare footage shows dolphins helping orcas hunt off B.C. coast

December 12, 2025

COMMENTARY: Possible relocation of Wildwood Golf Course is concerning residents

December 12, 2025

Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)

December 12, 2025

Driver, caregiver not to blame after child fatally struck by bus: Hamilton police

December 12, 2025

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Bombardier wins $753M federal contract to replace RCAF’s Challenger fleet

December 12, 2025

Alameda Health System reminds community: Apply for Medi-Cal before December 31, 2025

December 12, 2025

GeeFi Announces Major Community Giveaway to Celebrate Presale Success

December 12, 2025
Facebook X (Twitter) Pinterest TikTok Instagram
© 2025 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version